CLINICAL TRIALS PROFILE FOR LUBIPROSTONE
✉ Email this page to a colleague
All Clinical Trials for LUBIPROSTONE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00380250 ↗ | Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation | Completed | Takeda | Phase 3 | 2005-05-01 | The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation. |
NCT00380250 ↗ | Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation | Completed | Sucampo Pharma Americas, LLC | Phase 3 | 2005-05-01 | The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation. |
NCT00380250 ↗ | Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation | Completed | Sucampo Pharmaceuticals, Inc. | Phase 3 | 2005-05-01 | The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation. |
NCT00399542 ↗ | Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With Constipation | Completed | Sucampo Pharmaceuticals, Inc. | Phase 3 | 2005-05-01 | The primary purpose of this study is to evaluate the efficacy and safety of administration of lubiprostone in patients with irritable bowel syndrome with constipation. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for LUBIPROSTONE
Condition Name
Clinical Trial Locations for LUBIPROSTONE
Trials by Country
Clinical Trial Progress for LUBIPROSTONE
Clinical Trial Phase
Clinical Trial Sponsors for LUBIPROSTONE
Sponsor Name